BRCA1 and cancer: When near-complete and complete responses were combined, the difference between BRCA2- and BRCA1-associated cancers remained significant [9/15 (60%) vs. 12/48 (25%), Fisher’s exact test, two-tailed, P = 0.02] (Table 1).